Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Learn what you need to know about cash back taxes to optimize your financial strategies. Stay ahead in tax planning.
25,545 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
As investors digest Karyopharm's Q1 2026 earnings, this guide breaks down what to watch, how to interpret the numbers...
Geopolitical headlines drove a rush to buy the dip, yet the rebound failed to materialize for many investors. The epi...
After years watching Plug Power, I’m starting to see potential catalysts. This article lays out why the bear case rem...
TJX delivered a solid quarter, lifting confidence in a consumer-driven recovery. This analysis dives into whether com...
A high-profile insider move raises questions about strategy and sentiment. This article breaks down the Paychex share...
Price dips in tech stocks can hide real strength. This article explains why a stock with improving fundamentals might...
Oil tensions linked to Iran have put pressure on stocks, lifting energy prices and weighing on the S&P 500 and Nasdaq...
The Supreme Court struck down a key part of the Trump tariffs, but questions remain for importers about refunds and h...
A 41-year-old digital-marketing firm owner faced a $575,162 debt pile alongside a $620,000 home. The Ramsey Show weig...
Looking at Royal Caribbean in 2026, investors want clarity: is it a buy, hold, or sell? This guide breaks down the ca...
Dive into tomi (tomz) 2025 earnings and the Q4 transcript to understand revenue drivers, margins, and what it means f...